Health ❯ Healthcare ❯ Vaccine Development

Clinical Trials

Preclinical Research Sudan Strain Vaccine Butantan-DV Vaccine Vaccine Efficacy Cancer Vaccines Post-Marketing Surveillance mRNA Technology Adverse Effects Ebola Vaccines NIH Initiatives Placebo Testing ChAdOx2 RabG Animal Testing Phases of Vaccine Research Efficacy Studies Phase 3 Results Approval Processes Safety and Efficacy Phase 3 Trials Td Vaccine Manufacturing

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

Management stresses cost discipline to preserve cash under tighter U.S. vaccine guidance.

ACIP Shifts COVID Vaccine Guidance to Shared Decision-Making, Preserves Coverage

Most U.S. Adults Opt Out of Fall COVID-19 Booster, Poll Finds

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women